ARHGAP30

Chr 1

Rho GTPase activating protein 30

Enables GTPase activator activity. Involved in negative regulation of Rho protein signal transduction. Located in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2025]

OMIMResearchGenerating clinical summary…
LOFmechanismLOEUF 0.21
Clinical SummaryARHGAP30
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.21LOEUF
pLI 1.000
Z-score 5.56
OE 0.09 (0.040.21)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
-0.10Z-score
OE missense 1.01 (0.951.08)
635 obs / 627.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.09 (0.040.21)
00.351.4
Missense OE?1.01 (0.951.08)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 4 / 43.7Missense obs/exp: 635 / 627.8Syn Z: -0.18

This gene — mechanism propensity

DN
0.3693th %ile
GOF
0.5366th %ile
LOF
0.66top 25%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · LOEUF 0.21

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ARHGAP30 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →